UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 29, 2013

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-10030

APPLE INC.

(Exact name of registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).

Yes No

908,497,000 shares of common stock issued and outstanding as of July 12, 2013

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

Nine Months Ended

June 29,

2013

June 30,

2012

June 29,

2013

June 30,

2012

Net sales

35,323

35,023

133,438

120,542

Cost of sales

22,299

20,029

83,005

66,281

Gross margin

13,024

14,994

50,433

54,261

Operating expenses:

Research and development

1,178

876

3,307

2,475

Selling, general and administrative

2,645

2,545

8,157

7,489

Total operating expenses

3,823

3,421

11,464

9,964

Operating income

9,201

11,573

38,969

44,297

Other income/(expense), net

234

288

1,043

573

Income before provision for income taxes

9,435

11,861

40,012

44,870

Provision for income taxes

2,535

3,037

10,487

11,360

Net income

6,900

8,824

29,525

33,510

Earnings per share:

Basic

7.51

9.42

31.67

35.89

Diluted

7.47

9.32

31.44

35.48

Shares used in computing earnings per share:

Basic

918,618

936,596

932,388

933,672

Diluted

924,265

947,059

939,172

944,440

Cash dividends declared per common share

3.05

8.35

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

Nine Months Ended

June 29,

2013

June 30,

2012

June 29,

2013

June 30,

2012

Net income

6,900

8,824

29,525

33,510

Other comprehensive (loss)/income:

Change in foreign currency translation, net of tax

(100

(91

(177

(88

Change in unrecognized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax

188

150

791

216

Adjustment for net (gains)/losses realized and included in net income, net of tax

(357

(54

(203

(305

Total change in unrecognized gains/losses on derivative instruments, net of tax

(169

96

588

(89

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax

(883

22

(1,001

325

Adjustment for net (gains)/losses realized and included in net income, net of tax

(46

(19

(143

(59

Total change in unrealized gains/losses on marketable securities, net of tax

(929

(1,144

266

Total other comprehensive (loss)/income

(1,198

(733

89

Total comprehensive income

5,702

8,832

28,792

33,599

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands)

June 29,

2013

September 29,

2012

ASSETS:

Current assets:

Cash and cash equivalents

11,248

10,746

Short-term marketable securities

31,358

18,383

Accounts receivable, less allowances of $104 and $98, respectively

8,839

10,930

Inventories

1,697

791

Deferred tax assets

3,193

2,583

Vendor non-trade receivables

4,614

7,762

Other current assets

7,270

6,458

Total current assets

68,219

57,653

Long-term marketable securities

104,014

92,122

Property, plant and equipment, net

16,327

15,452

Goodwill

1,522

1,135

Acquired intangible assets, net

4,353

4,224

Other assets

5,421

5,478

Total assets

199,856

176,064

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

15,516

21,175

Accrued expenses

13,470

11,414

Deferred revenue

7,333

5,953

Total current liabilities

36,319

38,542

Deferred revenue non-current

2,672

2,648

Long-term debt

16,958

Other non-current liabilities

20,553

16,664

Total liabilities

76,502

57,854

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000 shares authorized; 908,442 and 939,208 shares issued and outstanding,

respectively

19,024

16,422

Retained earnings

104,564

101,289

Accumulated other comprehensive (loss)/income

(234

499

Total shareholders equity

123,354

118,210

Total liabilities and shareholders equity

199,856

176,064

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Nine Months Ended

June 29,

2013

June 30,

2012

Cash and cash equivalents, beginning of the period

10,746

9,815

Operating activities:

Net income

29,525

33,510

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

4,974

2,296

Share-based compensation expense

1,698

1,292

Deferred income tax expense

2,524

4,066

Changes in operating assets and liabilities:

Accounts receivable, net

2,091

(2,278

Inventories

(906

(346

Vendor non-trade receivables

3,148

(293

Other current and non-current assets

484

(3,238

Accounts payable

(4,740

2,450

Deferred revenue

1,404

2,575

Other current and non-current liabilities

3,556

1,686

Cash generated by operating activities

43,758

41,720

Investing activities:

Purchases of marketable securities

(122,681

(121,091

Proceeds from maturities of marketable securities

13,963

10,344

Proceeds from sales of marketable securities

81,734

73,140

Payments made in connection with business acquisitions, net

(443

(350

Payments for acquisition of property, plant and equipment

(6,210

(4,834

Payments for acquisition of intangible assets

(560

(1,067

Other

(188

(56

Cash used in investing activities

(34,385

(43,914

Financing activities:

Proceeds from issuance of common stock

335

433

Excess tax benefits from equity awards

644

1,036

Taxes paid related to net share settlement of equity awards

(1,001

(1,145

Dividends and dividend equivalent rights paid

(7,795

Repurchase of common stock

(17,950

Proceeds from issuance of long-term debt, net

16,896

Cash (used in)/generated by financing activities

(8,871

324

Increase/(decrease) in cash and cash equivalents

502

(1,870

Cash and cash equivalents, end of the period

11,248

7,945

Supplemental cash flow disclosure:

Cash paid for income taxes, net

7,188

5,901

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses, and

education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions

have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the

amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and notes

thereto have been reclassified to conform to the current period s presentation.

These condensed consolidated financial

statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 29, 2012, included in its Annual Report on Form 10-K (the

2012 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2013 will include 52 weeks, whereas fiscal year 2012 included 53 weeks. An additional

week was included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to particular years, quarters, months or periods refer to the Company s fiscal

years ended in September and the associated quarters, months or periods of those fiscal years.

During the first quarter of

2013, the Company adopted amended accounting standards that changed the presentation of comprehensive income. These standards increased the prominence of other comprehensive income ( OCI ) by eliminating the option to present components of

OCI as part of the statement of changes in shareholders equity and required the components of OCI to be presented either in a single continuous statement of comprehensive income or in two consecutive statements. The amended accounting

standards only impacted the financial statement presentation of OCI and did not change the components that are recognized in net income or OCI; accordingly, the adoption had no impact on the Company s financial position or results of

operations.

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share

is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been

outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units

( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the

Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the

three- and nine-month periods ended June 29, 2013 and June 30, 2012 (in thousands, except net income in millions and per share amounts):

Three Months Ended

Nine Months Ended

June 29,

2013

June 30,

2012

June 29,

2013

June 30,

2012

Numerator:

Net income

6,900

8,824

29,525

33,510

Denominator:

Weighted-average shares outstanding

918,618

936,596

932,388

933,672

Effect of dilutive securities

5,647

10,463

6,784

10,768

Weighted-average diluted shares

924,265

947,059

939,172

944,440

Basic earnings per share

7.51

9.42

31.67

35.89

Diluted earnings per share

7.47

9.32

31.44

35.48

Potentially dilutive securities representing 5.1 million and 4.4 million shares of common stock

for the three- and nine-month periods ended June 29, 2013, were excluded from the computation of diluted earnings per share because their effect would have been antidilutive. The number of potentially dilutive securities excluded from the

computation of diluted earnings per share because their effect would have been antidilutive was not significant for the three- and nine-month periods ended June 30, 2012.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category

recorded as cash and cash equivalents or short- or long-term marketable securities as of June 29, 2013 and September 29, 2012 (in millions):

June 29, 2013

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

6,196

6,196

6,196

Level 1 (a):

Money market funds

1,887

1,887

1,887

Mutual funds

3,974

(206

3,768

3,768

Subtotal

5,861

(206

5,655

1,887

3,768

Level 2 (b):

U.S. Treasury securities

31,329

11

(84

31,256

327

11,717

19,212

U.S. agency securities

18,200

(78

18,131

450

3,579

14,102

Non-U.S. government securities

4,899

29

(156

4,772

390

4,382

Certificates of deposit and time deposits

2,103

2,103

1,023

423

657

Commercial paper

2,996

2,996

1,365

1,631

Corporate securities

54,285

236

(379

54,142

8,920

45,222

Municipal securities

6,314

36

(40

6,310

915

5,395

Mortgage- and asset-backed securities

15,140

17

(98

15,059

15

15,044

Subtotal

135,266

338

(835

134,769

3,165

27,590

104,014

Total

147,323

338

(1,041

146,620

11,248

31,358

104,014

September 29, 2012

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

3,109

3,109

3,109

Level 1 (a):

Money market funds

1,460

1,460

1,460

Mutual funds

2,385

79

(2

2,462

2,462

Subtotal

3,845

79

(2

3,922

1,460

2,462

Level 2 (b):

U.S. Treasury securities

20,088

21

(1

20,108

2,608

3,525

13,975

U.S. agency securities

19,540

58

(1

19,597

1,460

1,884

16,253

Non-U.S. government securities

5,483

183

(2

5,664

84

1,034

4,546

Certificates of deposit and time deposits

2,189

2,191

1,106

202

883

Commercial paper

2,112

2,112

909

1,203

Corporate securities

46,261

568

(8

46,821

10

7,455

39,356

Municipal securities

5,645

74

5,719

618

5,101

Mortgage- and asset-backed securities

11,948

66

(6

12,008

12,008

Subtotal

113,266

972

(18

114,220

6,177

15,921

92,122

Total

120,220

1,051

(20

121,251

10,746

18,383

92,122

(a)

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

(b)

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and

liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

The net unrealized losses as of June 29, 2013 and net unrealized gains as of September 29, 2012

are related primarily to long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and

duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and nine-month periods ended June 29, 2013 and June 30, 2012. The maturities of the Company s

long-term marketable securities generally range from one to five years.

As of June 29, 2013 and September 29, 2012,

gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

As of June 29, 2013, the Company considered the declines in market value of its marketable securities investment portfolio to be temporary in nature and did not consider any of its investments

other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade,

with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company

reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates, and the Company s intent to sell, or

whether it is more likely than not it will be required to sell, the investment before recovery of the investment s cost basis. During the three- and nine-month periods ended June 29, 2013 and June 30, 2012, the Company did not

recognize any significant impairment charges.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter

into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s

subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion

of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases generally up to six

months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates,

the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other

instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.

The Company may

also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the

Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no

assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment of these instruments is based on whether the instruments are

designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. The effective portions of net

investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging

instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

The Company had a net deferred gain of $348 million and a net deferred loss of $240 million associated with cash flow hedges, net of

taxes, recorded in AOCI as of June 29, 2013 and September 29, 2012, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the

related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses

associated with cash flow hedges of interest income or expense are recognized as a component of other income/(expense), net in the same period as the related income or expense is recognized. The majority of the Company s hedged foreign currency

transactions and hedged interest rate transactions as of June 29, 2013 are expected to occur within six months and five years, respectively.

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within

a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are

reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during

the three- and nine-month periods ended June 29, 2013 and June 30, 2012.

The Company s unrealized net gains and losses on net investment hedges, included in the

cumulative translation adjustment account of AOCI, were not significant as of June 29, 2013 and September 29, 2012. The ineffective portions of and amounts excluded from the effectiveness test of net investment hedges are recorded in other

income and expense.

The gain/loss recognized in other income and expense for foreign currency forward and option contracts

not designated as hedging instruments was not significant during the three- and nine-month periods ended June 29, 2013 and June 30, 2012, respectively. These amounts represent the net gain or loss on the derivative contracts and do not

include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.

The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts

associated with outstanding or unsettled derivative instruments as of June 29, 2013 and September 29, 2012 (in millions):

June 29, 2013

September 29, 2012

Notional

Principal

Credit Risk

Amounts

Notional

Principal

Credit Risk

Amounts

Instruments designated as accounting hedges:

Foreign exchange contracts

29,489

585

41,970

140

Interest rate contracts

3,000

69

Instruments not designated as accounting hedges:

Foreign exchange contracts

11,635

84

13,403

12

The notional principal amounts for outstanding derivative instruments provide one measure of the

transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that

are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s gross exposure on these transactions may be

further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency and interest rates. Although the table above reflects the notional

principal and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon

settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of

transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments

fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of June 29, 2013, the Company received $642 million of cash collateral related to the

derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 29, 2012, the Company posted cash collateral related to the derivative

instruments under its collateral security arrangements of $278 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit-risk related

contingent features that would require it to post additional collateral as of June 29, 2013 or September 29, 2012.

10

The following tables show the Company s derivative instruments at gross fair value as

reflected in the Condensed Consolidated Balance Sheets as of June 29, 2013 and September 29, 2012 (in millions):

June 29, 2013